<SEC-DOCUMENT>0001144204-15-070741.txt : 20151214
<SEC-HEADER>0001144204-15-070741.hdr.sgml : 20151214
<ACCEPTANCE-DATETIME>20151214163418
ACCESSION NUMBER:		0001144204-15-070741
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20151214
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151214
DATE AS OF CHANGE:		20151214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		151286328

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v426559_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt">FORM
8-K</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT PURSUANT TO SECTION 13
OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of report (Date of earliest event reported):
<B>December 14, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CHAMPIONS ONCOLOGY, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; text-align: center; font-weight: bold">Delaware</TD>
    <TD STYLE="width: 40%; text-align: center; font-weight: bold">001-11504</TD>
    <TD STYLE="width: 30%; text-align: center; font-weight: bold">52-1401755</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(IRS Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">of Incorporation)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">1 University Plaza, Suite 307, Hackensack,
New Jersey 07601</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of Principal Executive Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Registrant&rsquo;s telephone number, including
area code: <B>(410) 369-0365</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former Name or Former Address if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION TO BE INCLUDED IN THE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 2.02.</B></TD><TD STYLE="text-align: justify"><B>Results of Operations and Financial Condition.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On December 14, 2015, Champion&rsquo;s Oncology,
Inc. (the &ldquo;Company&rdquo;) issued a press release regarding the Company&rsquo;s unaudited financial results for its fiscal
quarter ended October 31, 2015. A copy of the Company&rsquo;s press release is attached hereto as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information contained in this Current
Report shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
&ldquo;Exchange Act&rdquo;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference in such a filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 9.01.</B></TD><TD STYLE="text-align: justify"><B>Financial Statements and Exhibits.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><I>(d)</I></TD><TD STYLE="text-align: justify"><I>Exhibits</I></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibit filed herewith:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Exhibit No.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">99.1</TD><TD STYLE="text-align: justify">Press Release dated December 14, 2015</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>CHAMPIONS ONCOLOGY, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">(Registrant)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Date: December 14, 2015</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Joel Ackerman</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Joel Ackerman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v426559_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 86%; border-bottom: Black 2.25pt solid; font-size: 10pt; text-align: left"><IMG SRC="tex99-1_logo.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 14%; border-bottom: Black 2.25pt solid; font-size: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NEWS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #00000A">One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 201-808-8400</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><B>Champions Oncology Reports
Results for the Second Quarter Ended October 31, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Hackensack, NJ &ndash;
December 14, 2015 &ndash; Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services
to personalize the development and use of oncology drugs, today announced its financial results for the second quarter ended October
31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Second Quarter and Recent
Business Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #00000A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">Signed first large scale co-clinical trial with top 20 pharmaceutical company</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #00000A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">TOS revenue growth of 74%</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #00000A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">Continued progress in commercializing new ImmunoGraft product</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #00000A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">Signed sponsored research agreement with top 20 pharmaceutical company to expand platform into
hematology</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #00000A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify">Uplisted to NASDAQ Capital Market</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Joel Ackerman, Champions
Oncology CEO, stated, &ldquo;During this past quarter, we delivered on a number key milestones. We have been investing significant
resources over the last few years to grow the platform, accelerate the revenue growth and demonstrate the potential for PDX to
deliver multi-million dollar opportunities. This quarter was a major turning point for the Company along all these dimensions.
The co-clinical study we signed is the clearest proof to date of the $1 billion plus market potential of PDX and validates the
continued investment we are making in our platform. We expect these large co-clinical studies to combine with the new revenue potential
from our ImmunoGraft offering and our expansion into hematology modeling of acute myelogenous leukemia (AML) to drive continued
growth acceleration over the coming quarters and next year. This revenue growth, combined with strong expense control, has enabled
us to continue lowering our quarterly cash burn rate and we believe puts us on a path to cash flow breakeven.&rdquo;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Revenue was $3 million
and $1.9 million for the three months ended October 31, 2015 and 2014, respectively, an increase of $1.1 million or 57.9%. Revenue
was $5.8 million and $3.8 million for the six months ended October 31, 2015 and 2014, respectively, an increase of $2 million or
52.7%. Total operating expense was $5.5 million for both the three months ended October 31, 2015 and 2014. Total operating expense
was $11.1 million for both the six months ended October 31, 2015 and 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Champions reported a loss
before income tax expense of $2.5 million and $3.1 million for the three months ended October 31, 2015 and 2014, respectively,
a decrease of $600,000 or 18.4%. Excluding stock-based compensation of $748,000 and $820,000 for the three months ended October
31, 2015 and 2014, Champions recognized a net loss of $1.8 million and $2.3 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Champions reported a loss
before income tax expense of $5.4 million and $6.7 million for the six months ended October 31, 2015 and 2014, respectively, a
decrease of $1.3 million or 18.8%. Excluding stock-based compensation of $1.5 million and $1.6 million for the six months ended
October 31, 2015 and 2014, Champions recognized a net loss of $3.9 million and $5 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>Operating Results </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>Translational Oncology
Solutions (TOS): </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">TOS revenue was $2.5 million
and $1.4 million for the three months ended October 31, 2015 and 2014, respectively, an increase of $1.1 million, or 73.8%. The
increase is due to increased bookings, both in the number and size of the studies, in prior quarters due to the expansion of the
TOS sales team and growth of the platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">TOS cost of sales was
$1.4 million and $960,000 for the three months ended October 31, 2015 and 2014, respectively, an increase of $440,000, or 50.4%.
Gross margin was 41.9% and 32.9% for the three months ended October 31, 2015 and 2014, respectively. The improvement in gross
margin was due to higher TOS revenue, effective management of the variable lab costs and continuing leverage of the fixed cost
component of our lab.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>Personalized Oncology
Solutions (POS):</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">POS revenue was $486,000
and $452,000 for the three months ended October 31, 2015 and 2014, respectively, an increase of $34,000 or 7.5% as the result
of increases in our sequencing revenue offset by a decline in implant and panel revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Gross margin was (16.9%)
and (67.9%) for the three months ended October 31, 2015 and 2014, respectively as a result of aggressively managing our lab costs
and a shift to higher margin revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00000A">Research
and development expense was $919,000 and $1.2 million for three months ended October 31, 2015 and 2014, respectively, a decrease
of $281,000, or (26.4%). </FONT>The decrease is due to lower expenses in genomic characterization of our Champions TumorGraft
Bank for the current quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">Sales and marketing expense
for the three months ended October 31, 2015 and 2014 was $834,000 and $1.2 million, respectively, a decrease of $366,000 or (30.7%).
The decrease is due to lower public relations spend for POS and cost savings achieved by merging the sales and marketing resources
of the POS and TOS division, including combining both under one commercial business leader.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><FONT STYLE="font-size: 10pt">General
and administrative expense for the three months October 31, 2015 and 2014 was $1.7 million and $1.4 million, respectively, an increase
of $300,000, or 23.5%. The increase is due to an increase in stock based compensation for the President and CEO in lieu of cash
and due to the one-time costs associated with the uplisting to the Nasdaq exchange and related legal and filing fees.</FONT><FONT STYLE="font-size: 12pt">
</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>&nbsp;<FONT STYLE="color: #00000A"><B>&nbsp;</B></FONT></I></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>Conference Call Information
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">The Company will host
a conference call today at 4:30 p.m. EST (1:30 p.m. PST) to discuss its second quarter 2016 financial results. To access the conference
call, domestic participants should dial 800-875-3456, Canadian participants should dial 800-648-0973, and international participants
should dial 302-607-2001. The participant passcode is &ldquo;Champions Oncology.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00000A">Full details
of the Company&rsquo;s financial results will be available Tuesday, December 15, 2015 in the Company&rsquo;s Form 10-Q at</FONT>
<U>www.championsoncology.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>* Non-GAAP Financial
Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">See the attached Reconciliation
of GAAP net loss to non-GAAP net loss for an explanation of the amounts excluded to arrive at non-GAAP net loss and related non-GAAP
net loss per share amounts for the three and six months ended October 31, 2015 and 2014. Non-GAAP financial measures provide investors
and management with supplemental measures of operating performance and trends that facilitate comparisons between periods before
and after certain items that would not otherwise be apparent on a GAAP basis. Certain unusual or non-recurring items that management
does not believe affect the Company&rsquo;s basic operations do not meet the GAAP definition of unusual or non-recurring items.
Non-GAAP net loss and non-GAAP net loss per share are not, and should not be viewed as a substitute for similar GAAP items. Champions&rsquo;
defines non-GAAP dilutive loss per share amounts as non-GAAP net loss divided by the weighted average number of diluted shares
outstanding. Champions&rsquo; definition of non-GAAP net loss and non-GAAP diluted loss per share may differ from similarly named
measures used by others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Champions Oncology, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Champions Oncology, Inc. is engaged in
the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The Champions
TumorGraft technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors
in immune deficient mice followed by propagation of the resulting engraftments, or Champions TumorGrafts, in a manner that preserves
the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The Company
uses this technology in conjunction with related services to offer solutions for two customer groups: Personalized Oncology Solutions,
in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical
and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing
new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas as well as through
Champions&rsquo; Personalized Oncology Solutions business. For more information, please visit www.championsoncology.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release may contain &quot;forward-looking
statements&quot; (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.
Champions Oncology generally uses words such as &quot;believe,&quot; &quot;may,&quot; &quot;could,&quot; &quot;will,&quot; &quot;intend,&quot;
&quot;expect,&quot; &quot;anticipate,&quot; &quot;plan,&quot; and similar expressions to identify forward-looking statements. One
should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from
those anticipated in the forward-looking statements for many unforeseen factors. See Champions Oncology's Form 10-K for the fiscal
year ended April 30, 2015 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations
reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are
made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.
The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these
statements to actual results or to changes in Champions Oncology's expectations, except as required by law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><B>Champions Oncology, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #00000A"><I>(Dollars in thousands,
except per share amounts)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Reconciliation of
GAAP to Non-GAAP Net Loss (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended<BR> October 31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended <BR> October 31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Net loss - GAAP</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(2,548</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(3,078</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(5,461</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(6,684</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Less:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Stock-based compensation</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">748</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">820</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,523</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,627</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net (loss) income - non-GAAP</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,800</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,258</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,938</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(5,057</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Reconciliation of
GAAP EPS to Non-GAAP EPS (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended<BR> October 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended<BR> October 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Basic and diluted EPS - GAAP</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(0.29</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(0.55</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(0.63</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(1.20</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Less:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Effect of stock-based compensation on EPS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0.09</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0.15</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0.18</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0.29</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted EPS - non-GAAP</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.20</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.40</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.45</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.91</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Condensed Consolidated
Statements of Operations (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three&nbsp;Months&nbsp;Ended<BR> October&nbsp;31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six&nbsp;Months&nbsp;Ended<BR> October&nbsp;31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">POS operating revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">486</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">452</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">971</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">792</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">TOS operating revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,485</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,430</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,822</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,001</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Total operating revenue</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2,971</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1,882</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">5,793</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,793</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cost of POS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">568</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">759</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,228</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,516</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cost of TOS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,443</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">960</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,056</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,924</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">919</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,249</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,663</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Sales and marketing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,203</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,246</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,700</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,377</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,017</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,831</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.125in">Loss from Operations</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(2,493</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(3,666</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(5,390</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(7,387</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other (Expense) Income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(14</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">598</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(24</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">718</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.125in">Net Loss before income tax expense</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(2,507</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(3,068</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(5,414</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(6,669</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">41</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">47</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">15</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Net Loss</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,548</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(3,078</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(5,461</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(6,684</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B><U>Condensed Consolidated
Balance Sheets as of (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">October&nbsp;31,</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">April&nbsp;30,</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">2015</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="color: black; font-weight: bold; text-align: center">2015</TD><TD NOWRAP STYLE="color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; color: black; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 12%; color: black; text-align: right">4,157</TD><TD STYLE="width: 1%; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; color: black; text-align: left">$</TD><TD STYLE="width: 12%; color: black; text-align: right">9,357</TD><TD STYLE="width: 1%; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Accounts receivable</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,891</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">1,060</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Other current assets</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">295</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">346</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-left: 9pt">Total current assets</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">6,343</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">10,763</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left">Restricted cash</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">150</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">163</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Property and equipment, net</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">420</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">452</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Goodwill</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">669</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">669</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total assets</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">7,582</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">12,047</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Accounts payable and accrued liabilities</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">$</TD><TD STYLE="color: black; text-align: right">1,621</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">$</TD><TD STYLE="color: black; text-align: right">1,787</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">1,644</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">2,009</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-left: 9pt">Total current liabilities</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">3,265</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; text-align: right">3,796</TD><TD STYLE="color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; text-align: left">Other Non-current liabilitiy</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">215</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black">&nbsp;</TD>
    <TD STYLE="color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; text-align: right">192</TD><TD STYLE="color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: black; text-align: left; padding-bottom: 1pt">Stockholders&rsquo; equity</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">4,102</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: black; text-align: right">8,059</TD><TD STYLE="padding-bottom: 1pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">7,582</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: black; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; color: black; font-weight: bold; text-align: right">12,047</TD><TD STYLE="padding-bottom: 2.5pt; color: black; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B><U>Condensed Consolidated
Statements of Cash Flows (Unaudited):</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center">Six Months Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">October 31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left">Net Loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(5,461</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(6,684</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net cash used in operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,627</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt">Depreciation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Provision for bad debts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt">Change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(780</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Changes in operating assets and liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,299</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">480</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(5,127</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(5,247</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Purchases of property and equipment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(44</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(71</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(44</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(71</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Proceeds from exercise of options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt">Payment of issuance costs related to 2015 Private Placement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Capital lease payments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(11</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash (used in)/provided by financing activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(29</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Decrease in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,200</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,316</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Cash and cash equivalents, beginning of period</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,357</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">5,891</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, end of period</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,157</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">575</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00000A"><B></B>&nbsp;</P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tex99-1_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex99-1_logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P#8 P$1  (1 0,1 ?_$ +D   $#!0$! 0
M       '" D"! 4&"@,!"P$  00# 0$!              4&!P@#! D! @H0
M   & 0,"! 0$! ,%"0    $" P0%!@< $0@A$C$3% E!(A4646$R%Z%"(QAQ
M,QF!D;'A)%)B<I(E128V.!$  0(% P$&! ,' @0& P   0(# !$$!08A$@<Q
M05%A(A,(<8$R%)$5%J&QP4)2(S/A%_#QHD/18G*"-#62<R3_V@ , P$  A$#
M$0 _ ._C1!%A(/VT:@=X\<HM&C=-9=TY<J$1;H((IBHJLNLILFBBBF43&,82
ME*4!$1V#1L?<\E,@N5!("4CJ23+2,-14-4C*JFI4VW2-I)6M:@D( $YZZ?CT
MB"WF#[TU%QH]E*+QJC(W*UL:"X8/K](JJDQU#/DS&24)%%; D\MZS8Y>ITCH
ML^[]*J@:M%QQ[8<@R"G3?<NJ306Y<BEC:/6*9=9;?)X;E$]Z1.*&<P^^#&,9
MJW,<X^:_,ZY(4E=2=&D+!  2.C@ZS.@B _,W.GE=G5TN>_9FM)XQR<RGVS6E
MBU&KH%,)NUN2(@?2E<HI%'8!<J+G'Q$PCJW>-</\:XV&W;3;T.5+9_R/;G%%
M<@"1O) '@ !UD(YY9K[@.6\TJ5KO5U>;86)!IG8T@)F2-&TIF==2=>R&K*O7
M;OO4<+'<*J"(G46,94YA$0$1,903&,8?B(]1U(RK9:UG<JEIIRE_B0.GRB)G
M,@OJW"IRMJB3U)=7/]\;35LC7NC2"4K3;G9ZC*H'*<C^MS<E#.@,02B7N5CW
M"'F%^4.AMP';J Z2[AB6+W5HL7&@I'6E=4J;3+\)0IVK.,SLCWW%IN=:RX#,
M$.J_B3$H7'GWD.4F)73"/R6]89UIA#$([;61)M$75%J.Q3#&VN/:IE=+HE#N
M+Z]!P!QZ"< '<('S7VOX'DLU8HZY;*HS)!WK05DS(DM1D)Z )( '9I*+;<:>
M]KD;#ZU#>9(3=;.$I21M0AP  #=O0D$F769.L=*?%?FIA+EU6SRV,+%Y=BC$
M6Y[3CZ=!!C<ZPHJ?L,9['$.HF^C3G'9-XU.JV/N&YB&'L"CO(''.5<=70VO)
M65,#<-CJ/.VYX!4B-?D8Z?\ %O,V#<NV87'$*M#E6/\ (PX=CK8[9HZ_ ](=
MYIE1*\&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((
M-$$6[DY4T%%#J B0A3'45$X$!,A"B8YS',(%*4A0W$1^ :^5!:I):_RD^4=Y
M[O&,3Q0&5EQ90@))*ND@-29]F@CE%]TCW(IC,,]/<>\)6!PQQ#!NG47=K3'.
M%4W&2)=%447L6S=(B0Y:7%N$Q('8)?7K$,(B*12@:_O G!B;=0,YGDC*%7I<
MO2:4G_ !(AR1_G5XCRRTUG'([W5>Z*HS*Z.X%A#BT8S3J4T\ZVHI^X<&B@>]
M E\SJ=)1!^H(E\OM#L+MVE H;!V@(= #P -_P^.K?ONJ!09_W0-3VQ05U(']
MLK*U#KX&*C@)@*<YT2D P%$RA@*81$=@#PW'J/36N^YO'K52E!L"6[NE'U1B
MG*_36AU;JM $])]GSC?8/&62;&T*]KV,<@3S,0[O60].L;YH).NQRKM8Y1 Y
M>GB4PAIN5.48=1.FG?O%,TZ.J5J&X3[_ .'A#J;P++W$!QJVW)3:A,%-&XZ)
M>"TB1^7PC6)Z!F:VZ(SL<%+UYZH;8K":B7\0]W$=@*"4DW;'5'J'Z=]+-!=+
M?>&THL=51/JEHJ8.[QZQHW''KM:T 5U#6TBQU74-J:0?$)4D;1X3,HPXJE$>
MN^W@ [!ML'^[IK=6\\H>F\=Q&AE*6FAEX=T-S8I"M""0>SI_RA;>/4GFF*S1
M0%^/2]E)F TPBWI)*P3S'CUVH83JL7R*G_1NH%9(AA>)N]V?IP.97Y2[@Q^1
MF,)&'O?K-#)MI96 E8GZ<TD!2"=0L=4^,HESB*KY$1FM-7\7I6K*34(FA.B1
M-:9>H 0"V?Y_"<=Z>-W%[4I%0-DTD(ED)2#BPNR58,Z5KB-F%BD,PE"G>]KD
M8Y-Z!@3$V_QV$0V'7(.M5;6;B^+2JH>MZZA0;4O7:D$RGV 2[(_0%83?!8Z+
M]3I9&1*IDFH2Q_C2X0"J7;*>D_PA0M>0KP:((-$$&B"#1!!H@@T00:((-$$&
MB"#1!!H@@T00:((-$$&B"#1!!H@B(+W>>5;S _'Y/'=/E%8W(F<%WM:8O6ZQ
MBO(2DH-R!;YIN)3@H@Y<-G";%!3^11R)@ZEU//MXX\5E^8/7.\__ $E 0X-)
M@N:!M/=WJ/P'?%,/>?S"./>/48_9EJ1D5[29%*B%(8 (<4""""24@2([8X]C
MI]@B8IC"3HF7<1$0*4/E 1_PUT\5L;;0*?1H) F-)R[XXR/%Q&Q+A/K*3ZA^
M*CU^/>85K"6&L@\A,DUS%.,(-2;MEC7,1N0YA2CHF/0[#R,[-/>TY(Z'BT#>
M8LJ8.O0A0,<Q2F:V6YK8\"L;V1Y 2*1L2'>5D:"7;#RXWX[OW)V4,8ICZ0JM
M?6"2>@2/J)5T$AJ9QUR<1O:[X]<;XR'F+) 1F7LMIMTU9.\V^-0D(N->F^95
MK3ZV[%:/AV38WRIKJD6>* 4#&4#<"EYJ\C<Y9QGKZRT\[26F<FT,K+<T=BEE
M!$S(]-/&<=F>)?:OQGQ<PR_74";CD>S<M]T!QM*SU2E"II\LNI3/6)/F39NT
M;)MVJ#=L@D E30:HIMT$R@([%322 J9"A^ !J'UO./GU'5*6X1J5$DD^).L6
M8IJ=JE9##"6TLIG((2$I GT &@^7;"<Y&Q7CC+<.^K62*/5;K"/"&0<,;%#1
MTH7L, !WH*KI&<M%B^)3IF(<H@&PAI3MU[OEC?;J[+4O,K'78XI'[ 9'YZ0W
M<DQ#&,NH7+=E-L8JJ5?12VT+)'>"02GY$1SB<Y_9XF*B\^_N(L1)VV EY5FR
ME,2J/ >V&KJ/G1&:4G6I%V<AI6M(N% ]2DZ4,X8H[J HHF4P$NGP_P"YNAJT
M?DO)7D2T@R>2G;NVC0*EJ%:#4:*\"91S7YW]EUQMM<F\<2(#MO=4G=;5:O>8
M^9:%_P!&LY3&T:=(E-]O#V]JKQ JA;-92Q]FSQ:8]).UV9,2.6-:8K'(LI4:
M@<R13(1R)B!ZMT %4?*EZB"8$*%>^8.8+KR9>2A&YK%FS_:2#+<0?*5 =>\3
MT^<6[]OO -FX8LH<>2V]F%0G^\LI22D'JE*I3T[3/P^,G?8GN ]I-PZ@/:7<
M! -@$.GP#4-@[1M3H(LJ) S3H2)?$17HCV#?7DQ!!KV"#1X=L$&B"#1,00:(
M(-$$&B8@@T00:((-'2"#1!!HZP0:((-> @]((->P0;Z()B.-3WE,G.[SS3L5
M9*L9:)Q74ZQ38]$H[HMWKMD%DFC[%'8JRSB73*?H.X)%\-M=,/;)819^+TW%
M7^6YU!>EVR1N0F.(_O5RQ>4<SUE%.5/:D(IAKU,MRCW?43$5"9=S=/$WB'X"
M/PU8-""\13CHM0)\ G4D^ [3%26%E"7'!U2@C\=(ZX?9DXR1>+^.R&<96-2#
M(6=#*2J<@NW,+N+QXP>+M:W$-S'^9!&54;GD5@+L"@JI;[]A=N:/N:SJHRO/
M:FPL+"[9;O[8VD%*B>I!&A(Z:=-8[7>S;C2APKB^ER*L:6+M= 'O,DA242DG
M0B8"AJ#VB1!(B868E8^ BI&9EWC6.BHIFXD9!^]5(W:LF+-$[AVZ<*JB4B:2
M""1C&,/@ #JMJZFCI*53SWDI6D&>[R]-3UBV[]13TC3M56J2FF2"J9,@ !WG
MX1!?F;WGF\59)&)P=C.-M$!'+F03N%VE9*.;S0)@)3.(>OQB23M-DHH4WEJ.
M%BJ&*(&%( '4#7;G=+#ZVK31)>I$J("E*D21H=.Z?2*[WOW",TU2Y2V"B#S:
M"0%J4$A1'4CPG"W<3/=7IN<K;%8VRA46V,KG8%2LJY+-9,[VH6"44$?)B/.>
MD1>PTF[$ ! BPJ(K'$"%4 P@47/A7+=LRQ]-MK6TTU8=-A.D^Y,Y3^(TAQ81
MS3094\FW71M--7$A)!5Y2K^E),IGNEI$O9.I""(;")"[^(;;@'3J "&I?D!H
M.D3=IV=(3S(N2J#B:J2-SR-;J]2ZI&)[OIRQR:$:R24/L5)LF=4W>Z>+F'9-
M!(IUE!'8I1'II3M%INM^KDVZRT[M5<%* "&D*6J<P-0D$@:ZDR ZF&UD.2X]
MA-M7=<EK*:AM:4%2G'EI2DI ).T*(+AD#)"9J5T ,,EK7NE<&++8VM;9YPBV
M+MVY!JU>S];MM<@U5C&\LH*3\O"MHMNDHIL!5%U$2" [B(!I^5/"G)EMIW+@
MNSU!2!-P-H]1:1XH05+^6WQB&K+[I^";S=1:Z'(J+[I2MK?J,.,()_\ W.I2
MVB?>H@3TZF'9Y?SOBC!^.QRIDZW,J]02NXIM]S(HNYIBHO-K%2BP;!#-Y!=T
MB].(=BA"&((==]NNF;9,>O%_N9L]IIUO7()42U*2@$":I@RD0.H.L2CEF>XM
MA&/IR7(:WT+ ZXVD/M_W 5.F3826PJ:5'^83$M9RC8:QDFG77'\+E2L3 2E#
MG:V6VQ,XFS=IINX S0[TD@FS<-DGJ93-BB?L,F538-NW?24_:[DS=C9G*1'W
MGJAM0)3,*)D$_&>G=XPML9-:JK&QE;#Y_(4LE\NR.Y;2023*4Y2$SIV1I7'_
M ),X7Y,PT_8<+W9O=8FLRB4'..T(N7BO0RBK?UB38Z4PQ8JJ&4:F ^Y ,4 ^
M.EG),1R;#ZY-!D=*JD<<0%MH5HO;WE,] =-ID)ZRA+POD#$^1*!R\XC5BJMS
M:]BB.B5=9>!EK+NEWB,YG#.&,>/M&?Y)RS94*M3HU=@R=2BC9V_/ZN3= U8M
M6\?&H.9!ZX<+FV B29A H&,(=I3"&I8,8R#+KPFS8M2_<7Q394 !,A U5W:?
M,"/C/,ZQ/CZQ?J/,:K[>R^J&^_<XK4 2U)E,R'8)]D9;$&7L>9QQ_ Y-QA9&
MMGI=D!V:(ED4G+,5C,72S%Z@LQ?HMGS-TU=MSD.DJF0Y1#PV$!''>++<\<N2
M[/>FO0NJ/K0=#,B<QW@]XG"MBV2V++K&UD&-/BILSHFE8,P)=03V2[NR$\Y!
M<J,&\8&M=DLV7E"DLK8]>LH-PO#S4L1ZO&-4W3\@!"L'YT ;-U ,)E * @.P
M#OK=QO"LJS!Q\8G1A\L %XB4R.PRF)]".WITAM9SRI@W&BJ<9K6&F36JVLS!
MVS$OYI2&NNIA9H&W5NSUB'N5?FHZ6J\["M+#%3;9TF,>\A'K,KYM)$7.8I2M
MCM3 <3&[>T-^[;8=DFHHJJBJE6^H:4W5MK*"W([@M)D4RZS!TE#SH+M;:^U,
MWFD?;<M;S(=0[N3L4WMW;]T]NT)U49R ZP@&%.8/'?D19;/3L.9(87.PU!H:
M2L#%E%3C8C./"2&*!XD^D8MHQ>ME'WR$.@=0#@(&+N40'2_E6"YGB%,Q67ZW
M%AFI ](NR1OF)^74S,NO<=#(PR<#Y9X[Y$JJFCPVX"X/TJB'>H")**9S4 -L
M_I4)A0D02(TK+ON"\2L'WB8QEDW++.KW:!1CUI6&5KMI>BU+*LDG[ 1>QD*[
M:F]0U<$.42&-MOL(;]-+./<3\@Y'9V[_ &>U..T#B@GU$[=FZ<MLR1,STE#?
MR[GKB?"[LY8,MNOV]<A,]0=P$I[D@"9([)#7LC=L'\PN-_(QX[C,,Y7K-RF(
MQMZU_!I*NXB>19E$I#OB0TZSCI)RT2,8 .LDF8A!$ ,(;Z1LDP7,<46@Y';7
M::G<) 6I! )E.23(I/P"H7<*Y>P#D0%G";A3W!]J7E*TI>$S*?IJDO\ Z8R6
M1N4^#\491H>(K_=V\%?\FF:(TB!-%S3U2;,_D?I3/L=L8QS'M@7?E%,!663#
M?\NNM>U8;E%XL%1D-O9=7;*4_P!UP >FWW!9)TGIUC=OG).#6+*Z7#+I6K1E
M%8 6J525#U 3*:21(D$&0!FH@@ RA=9J:BJ_$O9R>E(V%AX=JO(2LK)NVS&,
MCF+9,ZJ[MZ]=*)MFK9)(HB8YS%*&WCIM4--5W!Y-(TP:FY*<" @ J5,_3)(!
M))[  2>R'I75UOM%*[<*];;5J9;*EN.*2A* .I*E$ 2[9F(^7?NM<$6=F/7E
M,ZQJSA-SZ4\FTK-Q=UT%@4!,3A/MZ^K&J-0$?\XBAD?^]MUU+2>#.8E47WJ;
M.[]M+Z-OGEU^G=NG+LVS\(KV[[J>!&KM^5"_K-1OE,)66!\7=OIR\=TO&'[U
M.W5R[5V.ME0G8>SUF=:I2$+/0;]I)Q,DR6*!B+M'K-11NL3X#L81*;Y1V$!#
M447*@K[54KH:FG-+=$.;%(4"E0(ZS20")>(Z:](GZUW6VWVB;N=N6T]:7D!2
M'&UI6E<^A"DD@D]TYPAD)RYX^V#.4OQSC<C1/[S0BKAM(4IXSE(]\*[-BC)N
M6K%X\CT(N2=)1[@JPI(+J'%/<0 >TVSGJ\&RRWXVG*7J)Q=H<2"'B $$'03,
MS(3T$P)PQ[7RUQU<LR>P!BY)3EC!(-(3+S 3($P 5RU4@$J':!.,IG3D]A3C
M2RK,IFFYH4MA<)9:&@'"D3,2I'\BW1(LNV*$+'O3H>6B<#"=4"EZ^.M3%\,S
M#+ ^G%+?ZJ*1(6^$R.U*NBNHT.LCKT,;F8<EXAQXY3,9C6II7*]PH8!T3N$@
M4A73=J"0>^%6M-\J%*J3^]6VP1-;J$/&#,2E@FW:,='L8[RP5*X<+NC)D3!0
M@AVE_48P@4 $1VTFVZU5-TKORVULN+N:E[0AM)4I1[=H3/<.NHT\8<%UOUFL
M-B7?[\^VS;FTS]1U0;3(]-Q40 ? ZSADM6]T#@Y;;.A5HK/4$VD'+HK5HZL,
M+9Z[ NUSJ@FF1&Q3D4RAB J8WRF453*/COMUU)-QX9Y1M5L%PN=G?"=LYA(.
MGBD35H->D0Q:O<YPA?[LFU6_(Z)+ZUA"4KIW$!2B=H 6I(3J= >AZB<<K'N%
MJJ*\U^2KA8QC+&RA*I['$P_TD(^*01V 1Z 5!$H!\-M=$.&D>GQA90!(?:3_
M !,<>O<.\Y4<T9(5S_\ L/W"&:*&,1!91'YE03,IV^.P%(<YA#P_2(:E ..-
M)==9!+PIG9 ?^F(?H6@ZXI+NC)3MG_YE$;1\5$2$?H%<6&#*+XVX#CXXA$V3
M7"^+TVY$_P! %-3(A4VWYB=01$?B(_CKC1DCQJ<BKZE4]ZZMTGP\YC]&G'5,
M:3!++3@>5%HI$_,- $?+H8;3[I4W.0O#;)AH,SA(9)U4H.77;"8%$H&8LL:U
MDP$Q>H).4]D3_B100\!U#W*S]52X@Z[2I*E%029=QA&Y=JJBCPIYVG!*E*VF
M7<>O\(Y*.G@&X[=!$>HB/B(B/Q'KJDZDD*,^IU_&*(HD1,=I)_;'LDZ<L%F\
M@R550?1ZZ#]BN@82K(/61P=-%T3AU(JDX2*8IO@(;^.E>V&H-6W5T:"BI9$@
MKO\ $=L;]&ZZ?0=HDE%<Q5;I]I _F^$=V&.)*4F<=T.7FP.$U*TNKR4N50O8
MH$H^@V+I^!R;%[3@[5/N&P;#J_-K<<<ME,Z[_F4PV3\2@$_MCH];'%OVRG>=
M,UK8;)/>2@$QSR^X(WFN5'N1X&X>V:;D8;$\<6O.Y!FT<&:%>NYZ.E[-891$
M1 4QF7,##A&LE! PMQ.<Q>HB W;XH33<>\&7?D^@:WWUUXL>H.K)/E1,]0-W
MF,O"?2.<O-;%TYB]S=LX8NC_ *6*T;27]AT]5"0%N2':2B:1/L$23W'VKN#U
MOJ2%13PW%U1.,,Q\BQU![*1-L42:'2,LE)S:KIRI,%DDR"1P+@JHF!03%$I^
MTP0?0\U\D6ZJ57?F;RC4!04%*&T[NX "7XQ9V\^V3A"\6UJUT]G:IW:123Z@
M205;2.I.BI]ND(U[O-7A*;[>CRH56,9PU:K%IQ3 P,0V()&45#QLFE'L&2)1
M$X@DT:(@ #N(]-Q$1T]?:RJIJ.9DU+JFW*JIIZM2BOZ9ELDSB//>I;J.V>W\
MV^B2INVTE70I2$Z:)<*0!TACN%O=ZQQC3C#0<'KX4RC,2U5Q<UH#J>9N($D.
M[>?15XP)1JFHX!R:/\Y<#B)@*/:'X[;O[(_;KD-PS.KR9-SMK=/^:(4&PX=\
MU."29!)U[ )@3EK$,V/W=V"U\6-8*+'=5OIL50T7U(FV3Z*P"-)D$G4ZB4X7
M;V#Q%/"G('N$H#^[D3X#W% 35)F/3;QVWTV/=WZB<]I6]V]Y%J:&[OV^4GY%
M)!\08D#V!U"'.-;K5.20PN[].[^RC]YEV1@_<[MO]S'*?COP4AYY"%KR$TRN
MN6IM=XU8-8I)XBNJ45W3E=)#SX6EHO7"*9Q^9R^1  $?#<X.:>XXPFMY86RN
MINCTV:1(2HE: )+4)#Z2X0GO\IA"]S56WS!RYCO"E)5M4UCI7'*FN*E)2&U[
M2$*5,@?1H!K_ )(N/:/R&OAS,W(O@O:I=N]1J%JGKKC-ZFZ0=-7[%NNBRL)H
MUR@8R*B4O%*,)0I4^FYEQ$ '?6M[CK/3W6Q67EFF:4W]S3I;J04D%M0U&X$3
M'4C\(W?9QE%5CEVO/!ETJ6W#25#RZ4A85ZJ0J1V$$@C:-W6+3WYT >UCC"T
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ME9.80,Z)D?$4F;-,4$6HJG/F;4B)IBCL\ 4@@5W)M$'_ )X-C='**2B0 )E
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M:?\ N#0@3*9%1FH]>OSB)\ ]K55RW?+[G?,(K[7D51<B6$H6!)@IG*8G,3D
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7$$&B"#1!!H@@T00:((-$$&B"#1!'_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
